Rabbit Anti-CSRP2 Recombinant Antibody (C2974) (V2LY-0125-LY83)

Guru, A., Lite, C., Freddy, A. J., Issac, P. K., Pasupuleti, M., Saraswathi, N. T., ... & Arockiaraj, J. (2021). Intracellular ROS scavenging and antioxidant regulation of WL15 from cysteine and glycine-rich protein 2 demonstrated in zebrafish in vivo model. Developmental & Comparative Immunology, 114, 103863.

Wang, S., Zhang, Y., Liu, Y., Zheng, R., Wu, Z., Fan, Y., ... & Liu, Y. (2020). Inhibition of CSRP2 promotes leukemia cell proliferation and correlates with relapse in adults with acute myeloid leukemia. OncoTargets and therapy, 13, 12549.

Chen, L., Long, X., Duan, S., Liu, X., Chen, J., Lan, J., ... & Zhou, J. (2020). CSRP2 suppresses colorectal cancer progression via p130Cas/Rac1 axis-meditated ERK, PAK, and HIPPO signaling pathways. Theranostics, 10(24), 11063.

Brown-Clay, J. D., Hoffman, C., Mao, X., Moreau, F., Marani, V., Casellas, C. P., ... & Thomas, C. (2019). Pro-Metastatic Matrix Metalloproteinase Expression is Induced by the Invadopodial and Cytoskeletal Regulators Glycine-and Cysteine-Rich Proteins 1 and 2. Available at SSRN 3352504.

Hoffmann, C., Mao, X., Brown-Clay, J., Moreau, F., Al Absi, A., Wurzer, H., ... & Thomas, C. (2018). Hypoxia promotes breast cancer cell invasion through HIF-1α-mediated up-regulation of the invadopodial actin bundling protein CSRP2. Scientific reports, 8(1), 1-14.

Kihara, T., Sugimoto, Y., Shinohara, S., Takaoka, S., & Miyake, J. (2017). Cysteine-rich protein 2 accelerates actin filament cluster formation. Plos one, 12(8), e0183085.

Wang, S. J., Wang, P. Z., Gale, R. P., Qin, Y. Z., Liu, Y. R., Lai, Y. Y., ... & Ruan, G. R. (2017). Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogenetics. Oncotarget, 8(22), 35984.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols